Complications and Management of Eptifibatide-Induced Thrombocytopenia.

Background: Eptifibatide is used in acute coronary syndromes to reversibly block platelet aggregation by inhibiting the platelet glycoprotein IIb/IIIa receptor. A serious adverse effect of eptifibatide is a profound drop in platelet count, termed eptifibatide-induced thrombocytopenia (EIT).

Objective: To provide insight into the types of complications and management of EIT.

Acute myocardial infarction from simultaneous total occlusion of the left circumflex and right coronary artery. A case report.

We report a case of an 82-year-old female presenting with symptoms of chest pain, nausea, dizziness and electrocardiographic evidence of ST segment elevation in inferior and ST depression in anterior leads. Emergent coronary angiogram showed totally occluded mid left circumflex and a totally occluded distal right coronary artery, there was no response to intracoronary nitroglycerin before intervention. Both arteries were successfully ballooned and stented.